Jason Drew Smith - 17 May 2021 Form 4 Insider Report for UroGen Pharma Ltd. (URGN)

Role: General Counsel
Signature: /s/ Jason D. Smith
Issuer symbol: URGN
Transactions as of: 17 May 2021
Net transactions value: +$39,275
Form type: 4
Filing time: 18 May 2021, 11:35:11 UTC
Next filing: 08 Jun 2021
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	URGN	Common Stock	Purchase	$39,275	+2,500		$15.71	2,500	17 May 2021	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $15.675 and 15.76, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range.

Content

The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $15.675 and 15.76, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range.